Johnson & Johnson
Price & Volume
Stats
See moreOpen | $229.76 |
Previous Close | $229.85 |
Day Range | $227.15-$229.76 |
52W Range | $142.16-$251.71 |
Market Cap | $547.2B |
Shares Short | 19M |
Financials
See moreRevenue (12 Mos) | $96.3B |
Revenue Growth (YoY) | 9.9% |
Gross Profit (12 Mos) | $65.5B |
Diluted EPS | $8.64 |
News
See moreYahoo Finance • 4 hours ago
Chlorpheniramine Maleate - Global Market Insights, Competitive Landscape & Industry Forecast to 2033 Featuring Viatris, Alkem Labs, Merck & Co., Johnson & Johnson, Capellon Pharma and More
Yahoo Finance • yesterday
AbbVie Expected to Post Durable Growth Into Mid-2030s, BofA Securities Says
Yahoo Finance • yesterday
Johnson & Johnson Appoints Ryan Koors as Vice President, Investor Relations
Yahoo Finance • yesterday
AC Immune First Quarter 2026 Financial and Corporate Updates
About
CEO | Mr. Joaquin Duato |
CFO | Mr. Joseph James Wolk CPA |
Address | One Johnson & Johnson Plaza, New Brunswick, NJ, United States, 08933 |
Sector | Healthcare |
Industry | Drug Manufacturers - General |
Full-Time Employees | 138,200 |